Healthcare conglomerate CVS Health Corporation (NYSE: CVS) on Wednesday announced third-quarter 2024 results, reporting a decrease in adjusted earnings and an increase in revenues. The top line exceeded estimates.
September-quarter adjusted profit decreased 51% year-over-year to $1.09 per share and missed analysts’ estimates. On a reported basis, net income was $87 million or $0.07 per share in Q3, compared to $2.26 billion or $1.75 per share in the prior-year quarter.
Meanwhile, revenues increased 6% year-over-year to $95.4 billion during the three months and topped expectations. Total same-store sales climbed 15.5% year-over-year.
“My commitment to our CVS Health colleagues and our customers is to drive focused execution of our integrated strategy to improve the health of the 185 million people we are privileged to serve.,” said CVS CEO David Joyner.
The post CVS Earnings: CVS Health Q3 adj. profit drops despite 6% revenue growth first appeared on AlphaStreet.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
